Phase
Condition
Skin Wounds
Hyponatremia
Treatment
Local treatment with silver sulphadiazine only
Local treatment with silver sulphadiazine followed by URGOCLEAN® dressing
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult patient
2nd degree burn with : Affected body surface between 0.25 et 10% Fibrinous surfacebetween 9 and 156 centimeter/meter square (major axis between 3 and 16 centimeter,minor axis of 3 centimeter minimum) One or more non-contiguous fibrinous surfaces
Exudative wet fibrin
Patient treated with silver sulphadiazine between Day 0 and Day 4
Patient affiliated to a social security scheme
Patient who signed a written consent to participate in the study
Exclusion
Exclusion Criteria:
Facial burn
Known diabetic patient
Patient with severe venous and / or arterial insufficiency (obliteratingarteriopathy of the lower limbs stage III and IV)
Allergy to one of the components of the URGOCLEAN® dressing (polyacrylate fibers,carboxymethylcellulose, paraffin oil, petroleum jelly)
Person under guardianship or curators
Patient deprived of liberty
Patient for whom silver sulphadiazine is contraindicated (last trimester ofpregnancy, lactating woman, allergy to sulfa drugs)
Patient treated with pre-impregnated interfaces (URGOTUL SAG®, IALUSET+®compresses,..) during initial care between Day 0 and Day 4
Study Design
Connect with a study center
Hôpital Edouard Herriot
Lyon, Rhone 69003
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.